The Valley Desk

NCT02981303 · Interventional trial

Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer

Overall registry status Completed

Phase 2

Conditions Advanced Melanoma, Triple-Negative Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov